Puration collaborates with Generex to develop CBD-infused water

US-based Puration has entered an agreement with Generex Biotechnology to produce cannabidiol-infused water NuGenerex CBD HydroHealth High Alkaline Water.

According to the agreement, Puration will be refining its patented extraction process to develop proprietary CBD formulations for NuGenerex CBD HydroHealth Water, which will be retailed as therapeutic supplements for health maintenance.

Puration said that the CBD used in the NuGenerex CBD HydroHealth product line will be derived from industrial hemp using a patented extraction process that yields ultra-purified and characterised CBD formulations.

Puration CEO Brian Shibley said: “In anticipation of the agreement announced today with Generex, we have already been working on new CBD extracts to support Generex’s therapeutic objectives.

“With our US Cannabis Health partners, we are confident in the potential of the new extracts to meet and exceed Generex’s expectations. We are honoured to be engaged by a company the calibre of Generex on this exciting project.”

Generex is also planning to build on Puration’s track record in developing and marketing CBD infused drinks in the sports nutrition market.

The agreement with Puration is said to provide a platform for Generex for exploring the possible acquisition of US Cannabis Health, a joint venture (JV) that includes Puration’s participation with other innovators.

Generex president and CEO Joseph Moscato said: “Subject to testing and corresponding regulatory approvals, we’re targeting a million-bottle launch of Generex CBD HydroHealth Water in 2019.

“Given the network of pharmacies Generex owns itself, we are confident we can achieve if not exceed our million-bottle launch target. Puration’s experience and the calibre of Puration’s underlying extraction technology combined with the recently updated production facilities of Puration’s co-packer are instrumental in Generex’s plan to rapidly launch NuGenerex CBD HydroHealth Water.”